IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Soleno Therapeutics Inc

CUSIP: 834203101 | 20 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Birchview Capital, LP245,127
0.8% of portfolio›$1.1M
StyleTurnoverLocationFiled
Birchview Capital, LP
245,127$1.1M0.8%CoreHighBurlington, VT2023-08-08